13F Data
13F filer · CIK 1381843

Atle Fund Management AB

STOCKHOLM, V7 · filing since Q4 2013 · last filing Jul 24, 2026
Reported value
$371.7M
+$62.0M vs prior
Positions
39
New / sold out
3 / 3
Added / reduced
16 / 20
Turnover
29.0%
buys $98.7M · sells $289.2M
Top-10 weight
48.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedMERCK & CO. INC+155,504+459.4%+$20.0M
NewBIOGEN INC+62,781–+$13.6M
AddedCVSCVS HEALTH CORP+122,329+514.6%+$12.7M
AddedIONIS PHARMACEUTICALS INC+109,258+392.0%+$8.7M
AddedTANGO THERAPEUTICS INC+168,642+563.7%+$5.3M
NewORUKA THERAPEUTI+54,886–+$5.2M
AddedNEWAMSTERDAM PHARMA CO NV+154,052+162.5%+$5.2M
AddedBOSTON SCIENTIFC+105,949+262.0%+$4.5M
AddedIRHYTHM TECHNOLOGIES INC+31,780+142.4%+$3.8M
AddedABIVAX SA+26,580+84.1%+$3.5M
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedREVOLUTION MEDICINES INC-544,168-88.2%$-101.9M
ReducedDEXCOM INC-512,486-87.7%$-34.5M
ReducedBICARA THERAPEUTICS INC-1,023,977-87.5%$-30.4M
ReducedCARDINAL HEALTH INC-85,052-78.3%$-20.2M
ReducedINTUITIVE SURGICAL INC-46,195-65.2%$-18.4M
ReducedLLYELI LILLY & CO-9,901-24.9%$-11.9M
ReducedCELCUITY INC-107,983-76.4%$-11.3M
ReducedMIRUM PHARMACEUTICALS INC-94,961-48.5%$-11.1M
ReducedABBVIE INC-43,856-40.5%$-11.0M
Sold outAMGEN INC-21,903-100.0%$-8.7M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $100.5MQ1 2014: $140.3MQ2 2014: $177.6MQ3 2014: $137.1MQ4 2014: $121.0MQ1 2015: $144.4MQ2 2015: $195.7MQ3 2015: $169.1MQ4 2015: $212.5MQ1 2016: $213.6MQ2 2016: $218.1MQ3 2016: $134.4MQ4 2016: $108.5MQ1 2017: $65.2MQ2 2017: $80.2MQ3 2017: $85.6MQ4 2017: $47.4MQ4 2020: $151.0MQ1 2021: $125.6MQ2 2021: $105.5MQ3 2021: $66.8MQ4 2021: $71.0MQ1 2022: $62.8MQ2 2022: $43.4MQ3 2022: $47.3MQ4 2022: $51.8MQ4 2023: $127.8MQ1 2024: $164.4MQ2 2024: $164.0MQ3 2024: $212.8MQ4 2024: $210.8MQ1 2025: $226.5MQ2 2025: $233.7MQ3 2025: $27.0MQ4 2025: $313.4MQ1 2026: $309.7MQ2 2026: $371.7M
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1LLYELI LILLY & CO29,821$35.8M9.62%
2MERCK & CO. INCCOM189,357$24.3M6.55%
3JNJJOHNSON & JOHNSON85,425$21.7M5.84%
4ABBVIE INCCOM64,325$16.2M4.35%
5CVSCVS HEALTH CORP146,102$15.1M4.07%
6THERMO FISHER SCIENTIFIC CORPCOM27,859$14.0M3.76%
7REVOLUTION MEDICINES INCCOM73,077$13.7M3.68%
8BIOGEN INCCOM62,781$13.6M3.65%
9NEUROCRINE BIOSCIENCES INCCOM72,898$12.3M3.31%
10MIRUM PHARMACEUTICALS INCCOM100,807$11.8M3.17%
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.